Everence Capital Management Inc. Reduces Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Everence Capital Management Inc. decreased its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 77.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,500 shares of the company's stock after selling 18,610 shares during the quarter. Everence Capital Management Inc.'s holdings in Henry Schein were worth $401,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Swedbank AB bought a new stake in shares of Henry Schein during the 1st quarter valued at about $215,998,000. Thompson Siegel & Walmsley LLC acquired a new stake in shares of Henry Schein during the 2nd quarter worth approximately $46,683,000. SG Americas Securities LLC increased its stake in shares of Henry Schein by 1,622.3% in the 3rd quarter. SG Americas Securities LLC now owns 458,828 shares of the company's stock valued at $33,449,000 after acquiring an additional 432,187 shares in the last quarter. Nuance Investments LLC lifted its position in shares of Henry Schein by 28.5% during the 1st quarter. Nuance Investments LLC now owns 1,755,190 shares of the company's stock valued at $132,552,000 after acquiring an additional 388,843 shares during the period. Finally, Magnetar Financial LLC boosted its stake in Henry Schein by 229.9% during the first quarter. Magnetar Financial LLC now owns 386,458 shares of the company's stock worth $29,185,000 after acquiring an additional 269,330 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.14% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

HSIC has been the subject of several research analyst reports. Evercore ISI lifted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research note on Tuesday, October 8th. Robert W. Baird dropped their price target on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 7th. UBS Group decreased their price objective on Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a report on Wednesday, August 7th. Baird R W raised Henry Schein from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 22nd. Finally, JPMorgan Chase & Co. cut their target price on Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a research report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein has a consensus rating of "Hold" and an average target price of $77.50.

Henry Schein Stock Performance

HSIC stock traded down $0.40 during midday trading on Tuesday, hitting $71.19. The company's stock had a trading volume of 578,544 shares, compared to its average volume of 1,328,438. The stock has a market cap of $9.12 billion, a price-to-earnings ratio of 24.05, a PEG ratio of 1.98 and a beta of 0.86. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The stock's 50-day moving average price is $70.50 and its 200 day moving average price is $69.83. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, topping analysts' consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.10 billion for the quarter, compared to the consensus estimate of $3.27 billion. During the same period in the previous year, the firm earned $1.31 EPS. The firm's quarterly revenue was up .0% on a year-over-year basis. On average, equities analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.